Current Assets
Accounts Receivable
Boston Scientific Accounts Receivable increased by 3.1% to $3.15B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.4%, from $2.81B to $3.15B. Over 5 years (FY 2020 to FY 2025), Accounts Receivable shows an upward trend with a 13.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 1, 2026
How to read this metric
An increasing trend relative to revenue may indicate collection difficulties or a shift in customer payment terms.
Detailed definition
This represents the balance of money owed to the company by customers for goods or services delivered, net of an allowan...
Peer comparison
Common in B2B healthcare; peers are monitored for days sales outstanding (DSO) trends.
Metric ID:
accounts_receivable_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.78B | $1.78B | $1.89B | $1.98B | $2.03B | $1.99B | $2.08B | $2.19B | $2.26B | $2.23B | $2.34B | $2.41B | $2.51B | $2.61B | $2.67B | $2.81B | $2.93B | $2.96B | $3.06B | $3.15B |
| QoQ Change | — | -0.2% | +6.1% | +4.9% | +2.8% | -2.4% | +4.7% | +5.5% | +3.1% | -1.5% | +5.0% | +3.2% | +3.8% | +4.2% | +2.2% | +5.2% | +4.3% | +1.2% | +3.3% | +3.1% |
| YoY Change | — | — | — | — | +14.2% | +11.7% | +10.2% | +10.9% | +11.2% | +12.1% | +12.5% | +10.0% | +10.8% | +17.3% | +14.1% | +16.3% | +16.8% | +13.4% | +14.7% | +12.4% |
Range$1.78B – $3.15B
CAGR+12.8%
Avg YoY Growth+13.0%
Median YoY Growth+12.4%
Current Streak10 quarters growth
Accounts Receivable at Other Companies
Frequently Asked Questions
- What is Boston Scientific's accounts receivable?
- Boston Scientific (BSX) reported accounts receivable of $3.15B in Q1 2026.
- How has Boston Scientific's accounts receivable changed year-over-year?
- Boston Scientific's accounts receivable increased by 12.4% year-over-year, from $2.81B to $3.15B.
- What is the long-term trend for Boston Scientific's accounts receivable?
- Over 5 years (2020 to 2025), Boston Scientific's accounts receivable has grown at a 13.3% compound annual growth rate (CAGR), from $1.64B to $3.06B.
- What does accounts receivable mean?
- The amount of money customers owe the company for products already delivered.